Bessemer Group Inc Jounce Therapeutics, Inc. Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$2.8 - $7.67 $77,238 - $211,576
-27,585 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$6.01 - $8.54 $94,465 - $134,231
15,718 Added 132.45%
27,585 $187,000
Q1 2021

May 13, 2021
BUY
$6.73 - $13.87 $11,441 - $23,579
1,700 Added 16.72%
11,867 $121,000
Q4 2020

Feb 09, 2021
BUY
$6.37 - $10.33 $64,763 - $105,025
10,167 New
10,167 $71,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email